ARTICLE | Clinical News
Revolade eltrombopag regulatory update
November 8, 2010 8:00 AM UTC
Japan's Ministry of Health, Labor and Welfare (MHLW) approved Revolade eltrombopag from GlaxoSmithKline to treat chronic idiopathic thrombocytopenic purpura (ITP). Revolade is approved in Europe, Vene...